Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices

T. W. Vickroy, K. M. Johnson

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Phencyclidine (PCP) elicits some behavioral and biochemical effects in rodents which resemble the effects of other central nervous system stimulants. Because an indirect dopaminergic agonist role has been proposed for PCP, we have compared the dopamine (DA)-releasing properties of PCP, amphetamine and certain nonamphetamine stimulants (methylphenidate, nomifensine, amfonelic acid). Striatal slices from male albino Sprague-Dawley rats were incubated with [3H]DA (10 nM) and then superfused in microperfusion chambers with a modified Tyrode's buffer (pH 7.4). Drug effects on [3H]DA release during depolarizing (40 mM KCl) and nondepolarizing (basal) conditions were determined by comparison with drug-free DA release rates in each preparation. PCP (3-100 μM) and all central nervous system stimulants tested produced a concentration-dependent increase of basal [3H]DA release (potency order: amfonelic acid, amphetamine > nomifensine, methylphenidate > PCP). At higher concentrations, PCP and the nonamphetamine stimulants also enhanced stimulated [3H]DA release. The effect of PCP on basal release was unchanged by the removal of extracellular calcium, addition of tetrodotoxin (1 μM) or pretreatment of rats with reserpine. Nomifensine (1 μM) enhanced the DA releasing actions of PCP and other nonamphetamine stimulants, but antagonized the DA releasing action of amphetamine. PCP, at concentrations which did not affect basal DA release (less than 1 μM), also antagonized the action of amphetamine. From these results, it appears that PCP enhanced DA release in a manner similar to the nonamphetamine class of central nervous system stimulants.

Original languageEnglish (US)
Pages (from-to)669-674
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume233
Issue number3
StatePublished - 1982

Fingerprint

Corpus Striatum
Phencyclidine
Dopamine Agents
Dopamine
Nomifensine
Amphetamine
Central Nervous System Stimulants
Methylphenidate
Reserpine
Dopamine Agonists
Tetrodotoxin
Sprague Dawley Rats
Rodentia
Buffers
Calcium

ASJC Scopus subject areas

  • Pharmacology

Cite this

Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices. / Vickroy, T. W.; Johnson, K. M.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 233, No. 3, 1982, p. 669-674.

Research output: Contribution to journalArticle

@article{b32b58b8a19245cd9a3a71646e02d035,
title = "Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices",
abstract = "Phencyclidine (PCP) elicits some behavioral and biochemical effects in rodents which resemble the effects of other central nervous system stimulants. Because an indirect dopaminergic agonist role has been proposed for PCP, we have compared the dopamine (DA)-releasing properties of PCP, amphetamine and certain nonamphetamine stimulants (methylphenidate, nomifensine, amfonelic acid). Striatal slices from male albino Sprague-Dawley rats were incubated with [3H]DA (10 nM) and then superfused in microperfusion chambers with a modified Tyrode's buffer (pH 7.4). Drug effects on [3H]DA release during depolarizing (40 mM KCl) and nondepolarizing (basal) conditions were determined by comparison with drug-free DA release rates in each preparation. PCP (3-100 μM) and all central nervous system stimulants tested produced a concentration-dependent increase of basal [3H]DA release (potency order: amfonelic acid, amphetamine > nomifensine, methylphenidate > PCP). At higher concentrations, PCP and the nonamphetamine stimulants also enhanced stimulated [3H]DA release. The effect of PCP on basal release was unchanged by the removal of extracellular calcium, addition of tetrodotoxin (1 μM) or pretreatment of rats with reserpine. Nomifensine (1 μM) enhanced the DA releasing actions of PCP and other nonamphetamine stimulants, but antagonized the DA releasing action of amphetamine. PCP, at concentrations which did not affect basal DA release (less than 1 μM), also antagonized the action of amphetamine. From these results, it appears that PCP enhanced DA release in a manner similar to the nonamphetamine class of central nervous system stimulants.",
author = "Vickroy, {T. W.} and Johnson, {K. M.}",
year = "1982",
language = "English (US)",
volume = "233",
pages = "669--674",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices

AU - Vickroy, T. W.

AU - Johnson, K. M.

PY - 1982

Y1 - 1982

N2 - Phencyclidine (PCP) elicits some behavioral and biochemical effects in rodents which resemble the effects of other central nervous system stimulants. Because an indirect dopaminergic agonist role has been proposed for PCP, we have compared the dopamine (DA)-releasing properties of PCP, amphetamine and certain nonamphetamine stimulants (methylphenidate, nomifensine, amfonelic acid). Striatal slices from male albino Sprague-Dawley rats were incubated with [3H]DA (10 nM) and then superfused in microperfusion chambers with a modified Tyrode's buffer (pH 7.4). Drug effects on [3H]DA release during depolarizing (40 mM KCl) and nondepolarizing (basal) conditions were determined by comparison with drug-free DA release rates in each preparation. PCP (3-100 μM) and all central nervous system stimulants tested produced a concentration-dependent increase of basal [3H]DA release (potency order: amfonelic acid, amphetamine > nomifensine, methylphenidate > PCP). At higher concentrations, PCP and the nonamphetamine stimulants also enhanced stimulated [3H]DA release. The effect of PCP on basal release was unchanged by the removal of extracellular calcium, addition of tetrodotoxin (1 μM) or pretreatment of rats with reserpine. Nomifensine (1 μM) enhanced the DA releasing actions of PCP and other nonamphetamine stimulants, but antagonized the DA releasing action of amphetamine. PCP, at concentrations which did not affect basal DA release (less than 1 μM), also antagonized the action of amphetamine. From these results, it appears that PCP enhanced DA release in a manner similar to the nonamphetamine class of central nervous system stimulants.

AB - Phencyclidine (PCP) elicits some behavioral and biochemical effects in rodents which resemble the effects of other central nervous system stimulants. Because an indirect dopaminergic agonist role has been proposed for PCP, we have compared the dopamine (DA)-releasing properties of PCP, amphetamine and certain nonamphetamine stimulants (methylphenidate, nomifensine, amfonelic acid). Striatal slices from male albino Sprague-Dawley rats were incubated with [3H]DA (10 nM) and then superfused in microperfusion chambers with a modified Tyrode's buffer (pH 7.4). Drug effects on [3H]DA release during depolarizing (40 mM KCl) and nondepolarizing (basal) conditions were determined by comparison with drug-free DA release rates in each preparation. PCP (3-100 μM) and all central nervous system stimulants tested produced a concentration-dependent increase of basal [3H]DA release (potency order: amfonelic acid, amphetamine > nomifensine, methylphenidate > PCP). At higher concentrations, PCP and the nonamphetamine stimulants also enhanced stimulated [3H]DA release. The effect of PCP on basal release was unchanged by the removal of extracellular calcium, addition of tetrodotoxin (1 μM) or pretreatment of rats with reserpine. Nomifensine (1 μM) enhanced the DA releasing actions of PCP and other nonamphetamine stimulants, but antagonized the DA releasing action of amphetamine. PCP, at concentrations which did not affect basal DA release (less than 1 μM), also antagonized the action of amphetamine. From these results, it appears that PCP enhanced DA release in a manner similar to the nonamphetamine class of central nervous system stimulants.

UR - http://www.scopus.com/inward/record.url?scp=0020388003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020388003&partnerID=8YFLogxK

M3 - Article

VL - 233

SP - 669

EP - 674

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -